Cullinan Therapeutics, Inc. (CGEM) Stock Total Returns
Growth of $10,000 chart
2021-04-21 to 2026-04-21 to
$
%
%
Loading chart…
Investment Performance
Final Value
$4,202
Total Return
-57.98%
CAGR
-15.92%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +0.21% |
| Median | -3.57% |
| Best | +82.71% |
| Worst | -34.03% |
| % of Windows Positive | 38.7% |
1-Year (252 Trading Days)
| Average | -4.08% |
| Median | -20.69% |
| Best | +206.37% |
| Worst | -75.99% |
| % of Windows Positive | 33.1% |
3-Year (756 Trading Days)
| Average | -23.39% |
| Median | -30.11% |
| Best | +48.76% |
| Worst | -56.78% |
| % of Windows Positive | 15.8% |
Risk Metrics
| Maximum Drawdown | -83.42% |
| Average Drawdown | -59.46% |
| Drawdown Duration | 1250 Trading Days (Unrecovered) |
| Sortino Ratio | 0.11 |
| Calmar Ratio | -0.19 |
| CVaR (5%) | -8.35% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +37.39% (+184.42% ann.) | +$3739.13 | $0.00 | $0.00 | $0.00 |
| 2025 | -15.02% | $1502.47 | $0.00 | $0.00 | $0.00 |
| 2024 | +19.53% | +$1952.90 | $0.00 | $0.00 | $0.00 |
| 2023 | -3.41% | $341.23 | $0.00 | $0.00 | $0.00 |
| 2022 | -31.63% | $3162.67 | $0.00 | $0.00 | $0.00 |
| 2021 partial | -48.41% (-49.19% ann.) | $4841.19 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Reopening reflation / fiscal boom / supply bottlenecks partial | January 8, 2021 – November 29, 2021 | -41.22% | -44.97% | $4122.37 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -35.61% | -37.34% | $3561.10 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +39.60% | +19.72% | +$3959.53 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 21, 2026 | -17.47% | -11.39% | $1746.96 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.